173 related articles for article (PubMed ID: 10327252)
1. Terminal transverse limb defects with tethering and omphalocele in a 17 week fetus following first trimester misoprostol exposure.
Genest DR; Di Salvo D; Rosenblatt MJ; Holmes LB
Clin Dysmorphol; 1999 Jan; 8(1):53-8. PubMed ID: 10327252
[TBL] [Abstract][Full Text] [Related]
2. Möbius syndrome in a neonate after mifepristone and misoprostol elective abortion failure.
Bos-Thompson MA; Hillaire-Buys D; Roux C; Faillie JL; Amram D
Ann Pharmacother; 2008 Jun; 42(6):888-92. PubMed ID: 18460590
[TBL] [Abstract][Full Text] [Related]
3. Randomized controlled trial of misoprostol for second-trimester pregnancy termination associated with fetal malformation.
Akoury HA; Hannah ME; Chitayat D; Thomas M; Winsor E; Ferris LE; Einarson TR; Seaward PG; Ryan G; Willan AR; Windrim R
Am J Obstet Gynecol; 2004 Mar; 190(3):755-62. PubMed ID: 15042010
[TBL] [Abstract][Full Text] [Related]
4. Congenital abnormalities in Brazilian children associated with misoprostol misuse in first trimester of pregnancy.
Gonzalez CH; Marques-Dias MJ; Kim CA; Sugayama SM; Da Paz JA; Huson SM; Holmes LB
Lancet; 1998 May; 351(9116):1624-7. PubMed ID: 9620717
[TBL] [Abstract][Full Text] [Related]
5. Is induced abortion with misoprostol a risk factor for late abortion or preterm delivery in subsequent pregnancies?
Winer N; Resche-Rigon M; Morin C; Ville Y; Rozenberg P
Eur J Obstet Gynecol Reprod Biol; 2009 Jul; 145(1):53-6. PubMed ID: 19427095
[TBL] [Abstract][Full Text] [Related]
6. Failed methotrexate termination of pregnancy: a case report.
Goffman D; Cole DS; Bobby P; Garry DJ
J Perinatol; 2006 Oct; 26(10):645-7. PubMed ID: 17006526
[TBL] [Abstract][Full Text] [Related]
7. Misoprostol embryotoxicity: clinical evaluation of fifteen patients with arthrogryposis.
Coelho KE; Sarmento MF; Veiga CM; Speck-Martins CE; Safatle HP; Castro CV; Niikawa N
Am J Med Genet; 2000 Dec; 95(4):297-301. PubMed ID: 11186880
[TBL] [Abstract][Full Text] [Related]
8. [Uterine rupture during second trimester abortion induced with misoprostol].
Petri AL
Ugeskr Laeger; 2003 Jul; 165(29):2894-5. PubMed ID: 12908361
[TBL] [Abstract][Full Text] [Related]
9. Second-trimester pregnancy termination with 600-microg vs. 400-microg vaginal misoprostol and systematic curettage postexpulsion: a randomized trial.
Carbonell JL; Torres MA; Reyes R; Ortega L; García-Gallego F; Sánchez C
Contraception; 2008 Jan; 77(1):50-5. PubMed ID: 18082667
[TBL] [Abstract][Full Text] [Related]
10. Misoprostol overdose during the first trimester of pregnancy.
Bentov Y; Sheiner E; Katz M
Eur J Obstet Gynecol Reprod Biol; 2004 Jul; 115(1):108-9. PubMed ID: 15223178
[TBL] [Abstract][Full Text] [Related]
11. Misoprostol preferable to ethacridine lactate for abortions at 13-20 weeks of pregnancy: Cuban experience.
Boza AV; de León RG; Castillo LS; Mariño DR; Mitchell EM
Reprod Health Matters; 2008 May; 16(31 Suppl):189-95. PubMed ID: 18772100
[TBL] [Abstract][Full Text] [Related]
12. Birth defects after exposure to misoprostol in the first trimester of pregnancy: prospective follow-up study.
Vauzelle C; Beghin D; Cournot MP; Elefant E
Reprod Toxicol; 2013 Apr; 36():98-103. PubMed ID: 23207166
[TBL] [Abstract][Full Text] [Related]
13. Möbius sequence in children exposed in utero to misoprostol: neuropathological study of three cases.
Marques-Dias MJ; Gonzalez CH; Rosemberg S
Birth Defects Res A Clin Mol Teratol; 2003 Dec; 67(12):1002-7. PubMed ID: 14745923
[TBL] [Abstract][Full Text] [Related]
14. Prenatal exposure to misoprostol and vascular disruption defects: a case-control study.
Vargas FR; Schuler-Faccini L; Brunoni D; Kim C; Meloni VF; Sugayama SM; Albano L; Llerena JC; Almeida JC; Duarte A; Cavalcanti DP; Goloni-Bertollo E; Conte A; Koren G; Addis A
Am J Med Genet; 2000 Dec; 95(4):302-6. PubMed ID: 11186881
[TBL] [Abstract][Full Text] [Related]
15. Rupture of uterus in the first trimester during medical termination of pregnancy for exomphalos using mifepristone/misoprostol.
Willmott FJ; Scherf C; Ford SM; Lim K
BJOG; 2008 Nov; 115(12):1575-7. PubMed ID: 19035994
[No Abstract] [Full Text] [Related]
16. [Misoprostol teratogenicity: a prospective study in Argentina].
Barbero P; Liascovich R; Valdez R; Moresco A
Arch Argent Pediatr; 2011 Jun; 109(3):226-31. PubMed ID: 21660388
[TBL] [Abstract][Full Text] [Related]
17. Is misoprostol teratogenic? Misoprostol use during early pregnancy and its association with Möbius' syndrome.
Pottie K
Can Fam Physician; 1999 Feb; 45():315-6. PubMed ID: 10065304
[No Abstract] [Full Text] [Related]
18. Uterine rupture after 400 micrograms misoprostol oral administration in the first trimester of pregnancy.
Hidar S; Jerbi M; Khaïri H
Reprod Toxicol; 2006 Apr; 21(3):223; author reply 224. PubMed ID: 16316741
[No Abstract] [Full Text] [Related]
19. Teratogen-induced limb defects.
Holmes LB
Am J Med Genet; 2002 Oct; 112(3):297-303. PubMed ID: 12357474
[TBL] [Abstract][Full Text] [Related]
20. Fetal methotrexate and misoprostol exposure: the past revisited.
Wheeler M; O'Meara P; Stanford M
Teratology; 2002 Aug; 66(2):73-6. PubMed ID: 12210010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]